On track towards Vision 2030 Solid revenue growth of 17% on the back of Line 3 in CDMO sterile Injectables EBITDA margins to expand going ... Feb 06
Fusion Pharmaceuticals Announces FDA Clearance of IND for FPI-1966 ... Jul 30
Top ten mid cap Indian pharma stocks , January 2021... Jan 07
The collaboration represents a true partnership that combines the expertise and intellectual property of each collaborator ... Nov 02
-Advertisements-